Back

BHB/HRS-1893 in non-obstructive hypertrophic cardiomyopathy

11 May 2026 (15:42 - 15:54)
Organised by: Logo
Congress Presentation Part of: Advances in cardiomyopathies Hypertrophic Cardiomyopathy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Limei Wang

Beijing (China)

4 More presentations in this session

Presentation thumbnail
sTTR variability and outcomes in ATTR-CM
Doctor S. Selvaraj (Durham, US)
Slides Video
Presentation thumbnail
RESOLVE-HCM: perhexiline on regression of LVH in symptomatic HCM
Professor J. Selvanayagam (Adelaide, AU)
Slides Video
Presentation thumbnail
Dose-dependent effects of aficamten vs metoprolol in MAPLE-HCM
Doctor P. Garcia-Pavia (Majadahonda, ES)
Slides Video
Presentation thumbnail
ATTRibute-CM: outpatient worsening heart failure in ATTR-CM
Professor M. Fontana (London, GB)
Slides Video

Access the full session

Session thumbnail
Advances in cardiomyopathies
Video

The Event

Event poster

Heart Failure 2026

11 May 2026 15:42 CET
You may be interested in
thumbnail
Congress Session
Advances in cardiomyopathies
thumbnail
Congress Presentation
Safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-1893 in patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind, placebo-controlled phase 1 trial
thumbnail
Congress Presentation
CIRRUS­HCM: A multiple-dose phase 2 study of safety, tolerability, and effects on hemodynamics and functional capacity of the novel cardiac sarcomere modulator EDG-7500 in hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources